GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Price-to-Funds-From-Operations

AngioLab (XKRX:251280) Price-to-Funds-From-Operations : (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


AngioLab (XKRX:251280) Business Description

Industry
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.